Jan Rutherford

Jan is a Partner at SEP with responsibility for new investments and investor relations activities and works closely with the limited partners across our funds.

With an operational and commercial background in the pharmaceutical industry, she leads SEP’s healthcare investment activities, with a particular interest in digital health.

Jan was heavily involved in SEP’s investment in BioVex, a cancer therapeutics company, and supported management through its sale to Amgen in a $1bn deal. She also led SEP’s investment in Exco InTouch, a leading provider of mobile patient communication and management solutions for clinical research and healthcare providers which was sold to ERT in December 2016 representing one of the most successful recent exits for a UK venture capital backed business in the digital health market.

Currently non-executive director of healthcare informatics business Aridhia and e-cancer screening tools development company Abcodia, she is also a Trustee of the National Deaf Children’s Society.

Back to Team Page